Stock Earnings

Question 1

Argent Biopharma Ltd'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Argent Biopharma Ltd'in toplam varlıkları $2 olup, net loss $-17'dir.

Question 2

RGTLF'ün temel finansal oranları nelerdir?

Accepted Answer

Argent Biopharma Ltd'in cari oranı 0.18, net kâr marjı 0, hisse başına satış $0'dir.

Question 3

Argent Biopharma Ltd'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Argent Biopharma Ltd largest revenue segment is Pharma, at a revenue of 804,832 in the most earnings release.For geography, Slovenia and Others is the primary market for Argent Biopharma Ltd, at a revenue of 440,443.

Question 4

Argent Biopharma Ltd kârlı mı?

Accepted Answer

no, son mali tablolara göre Argent Biopharma Ltd'in net loss $-17'dir.

Question 5

Argent Biopharma Ltd'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Argent Biopharma Ltd'in yükümlülüğü 11'dir.

Question 6

Argent Biopharma Ltd'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Argent Biopharma Ltd'in toplam tedavüldeki hisse sayısı 72.18'dir.

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	0	0	0	3	4	2
Revenue Growth (YoY)	--	--	-100%	-25%	100%	0%
Cost of Revenue	0	1	4	6	3	1
Gross Profit	0	-1	-3	-3	1	1
Selling, General & Admin	12	10	10	8	11	7
Research & Development	3	3	2	2	2	3
Operating Expenses	15	14	14	12	16	12
Other Non Operating Income (Expenses)	0	0	0	0	--	--
Pretax Income	-17	-17	-17	-21	-20	-15
Income Tax Expense	0	0	--	0	0	0
Net Income	-17	-17	-17	-20	-20	-15
Net Income Growth	0%	0%	-15%	0%	33%	-21%
Shares Outstanding (Diluted)	63.67	57.17	37.01	2.93	2.56	1.9
Shares Change (YoY)	25%	54%	1,162%	14%	35%	-100%
EPS (Diluted)	-0.28	-0.31	-0.47	-7.1	-7.92	-8.32
EPS Growth	-18%	-34%	-93%	-10%	-5%	61,119%
Free Cash Flow	-9	-9	-14	--	-14	-15
Free Cash Flow Per Share	-0.14	-0.15	-0.37	--	-5.45	-7.86
Gross Margin	0%	0%	0%	-100%	25%	50%
Operating Margin	0%	0%	0%	-500%	-350%	-550%
Profit Margin	0%	0%	0%	-666.66%	-500%	-750%
Free Cash Flow Margin	0%	0%	0%	--	-350%	-750%
EBITDA	--	-15	-17	-15	-14	-11
EBITDA Margin	--	0%	0%	-500%	-350%	-550%
D&A For EBITDA	--	0	1	0	0	0
EBIT	-15	-15	-18	-15	-14	-11
EBIT Margin	0%	0%	0%	-500%	-350%	-550%
Effective Tax Rate	0%	0%	--	0%	0%	0%

Argent Biopharma Ltd (RGTLF) Price

RGTLF Stock Price Chart

RGTLF Income

Follow-Up Questions